U.S. markets open in 2 hours 25 minutes

Avinger, Inc. (AVGR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.6800+0.0800 (+5.00%)
At close: 4:00PM EST

1.7200 +0.04 (2.38%)
Pre-Market: 7:00AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close1.6000
Open1.6800
Bid1.6800 x 2900
Ask1.7200 x 3000
Day's Range1.6300 - 1.7150
52 Week Range0.2140 - 2.6700
Volume3,065,284
Avg. Volume26,800,296
Market Cap159.469M
Beta (5Y Monthly)1.44
PE Ratio (TTM)N/A
EPS (TTM)-0.7630
Earnings DateNov 10, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Aegis Capital Corp. acted as Sole Bookrunner on a $14.4 Million Bought Deal Offering for Avinger, Inc. (NASDAQ: AVGR)
    ACCESSWIRE

    Aegis Capital Corp. acted as Sole Bookrunner on a $14.4 Million Bought Deal Offering for Avinger, Inc. (NASDAQ: AVGR)

    NEW YORK, NY / ACCESSWIRE / February 3, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $14.

  • ACCESSWIRE

    Avinger Tigereye CTO Crossing Featured in Live Case at LINC 2021

    REDWOOD CITY, CA / ACCESSWIRE / February 3, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that its Tigereye™ CTO crossing system and Pantheris atherectomy system were featured in a live case transmission on January 29 at the Leipzig Interventional Course (LINC) 2021.

  • ACCESSWIRE

    Avinger Closes $14.4 Million Bought Deal Offering of Common Stock

    REDWOOD CITY, CA / ACCESSWIRE / February 2, 2021 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the closing of an underwritten offering of 10,000,000 shares of common stock of the Company, at a price to the public of $1.